Patents
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
12/1999
12/23/1999WO1999066047A1 A vaccine-induced hepatitis b viral strain and uses thereof
12/23/1999WO1999066038A1 Angiostatin-binding protein
12/23/1999WO1999065939A1 INTERACTION OF p27(KIP1) WITH FKBP-12
12/23/1999WO1999065530A1 NrdD
12/23/1999WO1999065520A1 Egg surface proteins and methods for use for modulating fertility
12/23/1999WO1999065517A2 Therapeutic compositions that produce an immune response by altering the antigen
12/23/1999WO1999065515A2 Combination of radiotherapy and anti-angiogenic factors
12/23/1999WO1999065513A2 Pharmaceutical compositions for the treatment of helicobacter pylori-associated disorders
12/23/1999WO1999065501A1 A process for the treatment of organophosphate poisoning
12/23/1999WO1999065500A1 Preventing cerebral infarction through administration of adp-receptor antiplatelet and antihypertensive drugs in combination
12/23/1999WO1999065489A1 Methods for increasing levels of acetylcholine
12/23/1999WO1999065470A1 Particulate acellular tissue matrix
12/23/1999WO1999065466A1 Temperature-sensitive liposomal formulation
12/23/1999WO1999065462A2 Use of aminosterol derivatives as chloride ionphores
12/23/1999WO1999065456A1 Foaming composition for hair care
12/23/1999WO1999065309A1 Methods for increasing levels of acetylcholine
12/23/1999WO1999065307A1 Methods and compositions for treatment of aids-associated kaposi's sarcoma
12/23/1999WO1999053043A3 Herpes simplex virus latency associated transcript polypeptides
12/23/1999WO1999052516A3 Acylpeptide protease inhibitors to enhance cognitive function
12/23/1999WO1999042578A3 Modulation of cell proliferation, methods and reagents
12/23/1999WO1999039722A3 Compositions and methods for separating lens epithelial cells and preventing posterior capsular opacification
12/23/1999DE19852804C1 Pharmaceutical composition for manipulating angiogenesis
12/23/1999DE19825591A1 Pharmazeutische Kombinationen zum Ausgleich eines Testosteron-Defizits beim Mann mit gleichzeitigem Schutz der Prostata Pharmaceutical combinations to offset a deficit testosterone in men with prostate while protecting the
12/23/1999CA2335295A1 Methods for increasing levels of acetylcholine
12/23/1999CA2335038A1 Combination of radiotherapy and anti-angiogenic factors
12/23/1999CA2334805A1 Use of aminosterol derivatives as chloride ionphores
12/23/1999CA2333453A1 Methods for increasing levels of acetylcholine
12/23/1999CA2333221A1 Therapeutic compositions that produce an immune response by altering the antigen
12/23/1999CA2332997A1 A process for the treatment of organophosphate poisoning
12/23/1999CA2332173A1 A vaccine-induced hepatitis b viral strain and uses thereof
12/23/1999CA2331889A1 Nek-related and bub1-related protein kinases
12/23/1999CA2331834A1 Pharmaceutical compositions for the treatment of helicobacter pylori-associated disorders
12/23/1999CA2331382A1 Interaction of p27(kip1) with fkbp-12
12/23/1999CA2330840A1 Diagnostic method based on quantification of extramitochondrial dna
12/23/1999CA2330228A1 Angiostatin-binding protein
12/23/1999CA2330210A1 Proteasomal activity
12/23/1999CA2301665A1 Methods and compositions for treatment of aids-associated kaposi's sarcoma
12/22/1999EP0965623A1 Stabilized monomer adhesive compositions
12/22/1999EP0965351A2 Pharmaceutical composition for treating side-effects of a diet with reduced amount of carbohydrates
12/22/1999EP0965341A2 Combination of dofetilide and a calcium channel blocker
12/22/1999EP0965278A1 Dietetic food composition and dietetic method using such composition
12/22/1999EP0964921A1 Novel streptococcal ers
12/22/1999EP0964917A1 Age-1 polypeptides and related molecules and methods
12/22/1999EP0964870A2 Lsr receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications
12/22/1999EP0964697A1 Therapeutic applications of antigens or epitopes associated with impaired cellular peptide processing, e.g. expressed on rma-s cells transfected with a b7-1 gene
12/22/1999EP0964686A1 Methods and compositions for preventing or retarding the development of atherosclerotic lesions
12/22/1999EP0964682A1 A method of treating liver disease and like indications with vasodilating agents
12/22/1999EP0964680A1 Use of nitric oxide inhibitors for treating side effects of particulate drugs
12/22/1999EP0964679A1 Method for the treatment of neurological or neuropsychiatric disorders
12/22/1999EP0964678A1 Use of comt inhibitors for the manufacture of a medicament for the prevention of diabetic vascular dysfunctions
12/22/1999EP0964617A1 Structure-based rational design of compounds to inhibit papillomavirus infection
12/22/1999EP0910385A4 Sensitization of cells to radiation and chemotherapy
12/22/1999EP0910362A4 Oxa acids and related compounds for treating skin conditions
12/22/1999EP0876160B1 Ligand directed enzyme prodrug therapy
12/22/1999EP0711167A4 Methods of enhancing opiate analgesic potency or detoxifying an opiate addict
12/22/1999CN1239437A Mitochondrial membrane stabilizer
12/22/1999CN1239433A Methods and compsns. for stimulating neurite growth using compounds with affinity for PKBP12 in combination with neurotrophic factors
12/22/1999CN1047507C Bevrage and enriched beverage for enhancing bioavailability of beta-carotene
12/22/1999CA2274741A1 Use of a compound having an affinity for the mitochondrial benzodiazepine receptor in cancer therapy
12/21/1999US6005080 Nucleotide sequences and expression vectors encoding hu-b1.219 gene product; molecular probes designed from its nucleotide sequence may be useful for prenatal testing and cancer diagnosis
12/21/1999US6005074 Cloning of human GPR14 receptor
12/21/1999US6005020 Bioresorbable compositions for implantable prostheses
12/21/1999US6004993 N-linked sulfonamide of heterocyclic thioester hair growth compounds and uses
12/21/1999US6004987 Use of ligands which are specific for RXR receptors
12/21/1999US6004972 Therapeutic process for the treatment of the pathologies of type II diabetes
12/21/1999US6004970 Administering with nicotine and drug enhancer
12/21/1999US6004953 Administering synergistic mixture of ascorbic acid and cobalt or iron phthalo- or naphthalocyanine complex; side effect reduction; anticarcinogenic agents; catalysis
12/21/1999US6004945 Use of adenosine compounds to relieve pain
12/21/1999US6004927 Coadministering bioenhancer comprising inhibior of cytochrome p450 3a or p-glycoprotein-mediated membrane transport
12/21/1999US6004803 Genes encoding HSV1-TK containing a deletion of 5' cryptic promoter sites, vectors and cell lines
12/21/1999US6004792 Amino acid sequence of enzyme which controls intracellular lipids; for antiinflammatory/antiproliferative/ anticarcinogenic agents; diagnosis and prevention of autoimmune, gastrointestinal, and cardiovascular disorders
12/21/1999US6004764 Screening methods for potential therapeutic agents which regulate the growth of m. tuberculosis; method for identifying genes of m. tuberculosis which are regulated by a sigma factor of m. tuberculosis
12/21/1999US6004746 Interaction trap systems for detecting protein interactions
12/21/1999US6004565 Administering fingolimod hydrochloride
12/21/1999US6004559 Plant material is extracted using an organic solvent, preferably acetone, then saturated with reducing agent acids to reduce toxic ndga quinone, which naturally occurs in the plant material, to ndga; antiinflammatory, antiviral agents
12/21/1999US6004554 Methods for targeting the vasculature of solid tumors
12/21/1999US6004552 Administration of a monoclonal antibody capable of binding to a human cd40 antigen located on the surface of a human b cell, wherein the binding of the antibody to the cd40 antigen prevents the growth or differentiation of the b cell
12/21/1999US6004550 Intracellular expression of carboxypeptidase G2 in a nitrogen mustard prodrug system
12/21/1999US6003516 Method for treatment of cancer and infectious disease
12/16/1999WO1999065228A2 Pharmaceutical combination used to compensate for a testosterone deficiency while protecting the prostate
12/16/1999WO1999064606A1 Tankyrase, a trfi binding protein
12/16/1999WO1999064596A2 Proteins regulating gene expression
12/16/1999WO1999064593A2 Cell cycle regulation proteins
12/16/1999WO1999064570A1 Novel methods and interferon deficient substrates for the propagation of viruses
12/16/1999WO1999064469A1 FIXATION INHIBITORS FOR $i(HELICOBACTER PYLORI)
12/16/1999WO1999064464A2 Method for producing or enhancing a t-cell response against a target cell using a complex comprising an hla class i molecule and an attaching means
12/16/1999WO1999064463A1 Monoclonal antibodies specific for guanidino group-derived advanced glycosylation endproducts in biological samples
12/16/1999WO1999064435A1 The human kidney specific gene kk86
12/16/1999WO1999064395A1 Heterocyclic amide compounds as cell adhesion inhibitors
12/16/1999WO1999064378A2 Directed combinatorial compound library and high throughput assays for screening same
12/16/1999WO1999064068A1 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
12/16/1999WO1999064061A1 GLUCAGON-LIKE PEPTIDE-1 IMPROVES β-CELL RESPONSE TO GLUCOSE IN SUBJECTS WITH IMPAIRED GLUCOSE TOLERANCE
12/16/1999WO1999064055A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999WO1999064053A1 β3-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064052A1 Novel leukotriene receptor antagonists and their uses
12/16/1999WO1999064050A1 Novel potassium channel drugs and their uses
12/16/1999WO1999064045A1 Novel therapeutic agents for membrane transporters
12/16/1999WO1999064042A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999WO1999064041A1 Multibinding agents that modulate nmda receptors
12/16/1999WO1999064038A1 Novel analgesic agents